- Oops!Something went wrong.Please try again later.
ARMK earnings call for the period ending April 2, 2021.
THE MONEYIST Dear Quentin, I loaned my sister $20,000 to help her buy a new home. We did not put any terms in writing, but she said that she would repay the loan in six months. (If it took longer to repay, and that was OK with me.
GlaxoSmithKline has unveiled plans for "the most significant change in more than 20 years", slashing the dividend by almost half in a bid to turbocharge growth and keep Dame Emma Walmsley at the helm. GSK, one of the biggest companies on the FTSE 100, said it would list 80pc of its stake in the consumer healthcare business on the London Stock Exchange and sell down its remaining holding in the short term. The move is expected to raise some questions among shareholders, who had been keen to carve
American Eagle Outfitters investors are basking in some gains thanks to star Brooke Shields and her daughters.
Zero-emissions transportation and infrastructure solutions provider Nikola Corp. (NKLA) is investing $50 million in Wabash Valley Resources for a 20% stake in the clean hydrogen project under development in West Terre Haute, Ind. The hydrogen project will utilize solid waste byproducts to produce clean and sustainable hydrogen for transport fuel and baseload electricity generation, while simultaneously achieving permanent underground sequestration of captured CO2. Significantly, upon completion,
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]
Shares of Biogen Inc. were up 0.8% in premarket trading on Wednesday after the company and Eisai Inc. said they plan to speed up the completion of what is called a "confirmatory" clinical trial for its recently approved Alzheimer's disease treatment. In the weeks since the drug's approval in the U.S., Aduhelm has faced criticism over how it was priced and whether or not the clinical data were strong enough to support the approval. In the new statement, the companies said they they now plan to co
Supermajors are piling into the world’s hottest offshore drilling location after a string of major discoveries
Piper Sandler analyst Alexander Potter published a detailed forecast for electric-vehicle sales for the coming generation. Some investors aren't going to like it.
'My goals are 100% in sync with those of the foundation, and my physical participation is in no way needed to achieve these goals,' Buffett writes.
Cardano (ADA) has been decreasing since May 16 but bounced at a long-term ascending support line on June 22.
Mark Cuban, the billionaire owner of the Dallas Mavericks, recently tweeted and blogged about Dogecoin (CCC:DOGE-USD) and investing in cryptocurrencies. Source: Shutterstock According to Yahoo Finance, Cuban wrote, “There is an incredible amount of competition. So much in fact, many, if not most will not work. They will not get enough users or generate enough fees to succeed … Crypto is brutally competitive.” He went on to say, “[A]ll other things being equal, I’m taking crypto every time.”Inves
A recent piece highlighted why Nio (NIO) may be a better long-term growth play than Tesla (TSLA). Certainly, that sentiment appears to be holding true, at least since that article was published. Since that May 26 piece, Nio’s stock price is up approximately 23% at the time of writing. However, investors in TSLA stock have seen an increase of only 2.9% over this time frame. There are a number of reasons why this may be the case. It appears investors are starting to factor in Nio’s unique market p
Top news and what to watch in the markets on Wednesday, June 23, 2021.
Plug Power's first-quarter earnings report was good enough for weary investors wanting to put accounting issues behind them. Now Wall Street is weighing in.
‘My wife earns about $35,000 a year. She's stated that she doesn't want to let her employer down by quitting.’
We’ve heard a lot in the news about the re-emergence of inflationary worries, but investors appear to have made a collective decision not to take fright. They sending the markets higher, apparently in the unconscious belief that equity gains can outpace inflation. The NASDAQ and S&P both started this week on an up note, and both indexes have shown solid year-to-date gains – ~11% on the NASDAQ, and 13% on the S&P. This is clearly outpacing the roughly 6% annualized inflationary trend. Chiming in
Even before the pandemic, as a mid-level employee tasked with hiring low-wage workers, it was clear to me that America had a pay problem.
IBM (NYSE:IBM) produced stellar first-quarter earnings on Apr. 19, with huge implications for the stock. Most importantly, the company’s cloud-based software earnings are now on a clear recurring growth path. I estimate IBM stock is now worth at least one-fourth more at $183 per share. Moreover, the stock is also cheap. Source: shutterstock.com/LCV IBM’s revenue grew just 1% for the quarter, but its cloud-based revenue was up 21% (slightly less after adjustments). Moreover, over the last 12 mont
During Monday's "Lightning Round" segment of Mad Money, one caller asked Jim Cramer about Sesen Bio : "Take some profits off the table," was Cramer's advice about the company that was formerly Eleven Biotherapeutics. Sesen Bio is a late-stage clinical company that provides a targeted protein therapeutics (TPT) platform. In this daily bar chart of SESN, below, we can see how prices have charged higher the past 12 months.
The spinoff of the consumer health business will allow the remaining company to increase sales by more than 5% a year for the next half decade, management said.